prulifloxacin has been researched along with Escherichia coli Infections in 4 studies
*Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazuno, K; Kise, M; Kitano, M; Matsuda, M; Matsuoka, M; Ozaki, M; Segawa, J; Shirahase, I; Tomii, Y | 1 |
| De Vecchi, E; Drago, L; Mattina, R; Nicola, L | 1 |
| Gualco, L; Marchese, A; Schito, AM; Schito, GC | 1 |
| Adachi, T; Honmura, T; Matsuda, M; Nishimura, I; Nishino, T; Okawa, Y; Ozaki, M; Tomii, Y; Yamaguchi, R | 1 |
4 other study(ies) available for prulifloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Carboxylic Acids; Escherichia coli Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Quinolones; Structure-Activity Relationship | 1992 |
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Respiratory Tract Infections; Selection, Genetic; Urinary Tract Infections | 2010 |
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
Topics: Anti-Infective Agents, Urinary; Bacterial Adhesion; Ciprofloxacin; Dioxolanes; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hemolysin Proteins; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Ultraviolet Rays; Urinary Tract Infections | 2007 |
Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Area Under Curve; Dioxolanes; Escherichia coli Infections; Fluoroquinolones; Half-Life; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Piperazines; Quinolones; Urinary Tract Infections | 1996 |